Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice

Scandinavian Journal of Immunology

Volumn 68, Issue 6, 2008, Pages 565-571

  Tschoeke, S K ^a,b   Oberholzer, C ^a,b   LaFace, D ^c   Hutchins, B ^c   Moldawer, L L ^a,b   Oberholzer, A ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; INTERLEUKIN 10; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL LIGATION; FEMALE; GENE THERAPY; IMMUNOREGULATION; LYMPHOCYTE; MORTALITY; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; SURVIVAL; THYMOCYTE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CASPASE 3; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE THERAPY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SEPSIS; THYMUS GLAND;

EID: 55349143535     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02176.x     Document Type: Article

References (39)

1. Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008 36 : 296 327.
2. Dinarello CA. Anti-cytokine therapies in response to systemic infection. J Investig Dermatol Symp Proc 2001 6 : 244 50.
3. Docke WD, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997 3 : 678 81.
4. Hotchkiss RS, Swanson PE, Freeman BD et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999 27 : 1230 51.
5. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J 2001 15 : 879 92.
6. Hotchkiss RS, Swanson PE, Knudson CM et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 1999 162 : 4148 56.
7. Weaver JG, Rouse MS, Steckelberg JM, Badley AD. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J 2004 18 : 1185 91.
8. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002 30 : S58 63.
9. Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 2002 168 : 6404 11.
10. Kumar A, Zanotti S, Bunnell G et al. Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular response. Crit Care Med 2005 33 : 331 40.
11. Lauw FN, Pajkrt D, Hack CE, Kurimoto M, van Deventer SJ, van der Poll T. Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 2000 165 : 2783 9.
12. Scott MJ, Hoth JJ, Turina M, Woods DR, Cheadle WG. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection. Cytokine 2006 33 : 79 86.
13. Oberholzer A, Oberholzer C, Bahjat KS et al. Increased survival in sepsis by in vivo adenovirus-induced expression of IL-10 in dendritic cells. J Immunol 2002 168 : 3412 8.
14. Oberholzer C, Oberholzer A, Bahjat FR et al. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci USA 2001 98 : 11503 8.
15. Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983 94 : 331 5.
16. Keravala A, Lechman ER, Nash J, Mi Z, Robbins PD. Human, viral or mutant human IL-10 expressed after local adenovirus-mediated gene transfer are equally effective in ameliorating disease pathology in a rabbit knee model of antigen-induced arthritis. Arthritis Res Ther 2006 8 : R91.
17. Oberholzer A, Oberholzer C, Efron PA et al. Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis. Shock 2005 23 : 507 15.
18. Minter RM, Rectenwald JE, Fukuzuka K et al. TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung. J Immunol 2000 164 : 443 51.
19. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995 3 : 207 20.
20. Oberholzer A, Souza SM, Tschoeke SK et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005 23 : 488 93.
21. Dimopoulou I, Orfanos S, Kotanidou A et al. Plasma pro- and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine 2008 41 : 263 7.
22. Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008 199 : 3 11.
23. Laterre PF. Clinical trials in severe sepsis with drotrecogin alfa (activated). Crit Care 2007 11 (Suppl. 5 S5.
24. Mees ST, Dohm C, Broetzmann K et al. Age- and gender-related differences of the immune function in a murine model of hemorrhagic shock: IL-10 restores immunodepression in aged females without reduction of mortality. Langenbecks Arch Surg 2007 392 : 629 38.
25. Rajan S, Vyas D, Clark AT et al. Intestine-specific overexpression of IL-10 improves survival in polymicrobial sepsis. Shock 2008 29 : 483 9
26. Scumpia PO, Delano MJ, Kelly-Scumpia KM et al. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood 2007 110 : 3673 81.
27. Tschoeke SK, Ertel W. Immunoparalysis after multiple trauma. Injury 2007 38 : 1346 57.
28. Buras JA, Holt D, Orlow D, Belikoff B, Pavlides S, Reenstra WR. Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Crit Care Med 2006 34 : 2624 9.
29. Tamion F, Richard V, Renet S, Thuillez C. Protective effects of heme-oxygenase expression against endotoxic shock: inhibition of tumor necrosis factor-alpha and augmentation of interleukin-10. J Trauma 2006 61 : 1078 84.
30. Gomes RN, Figueiredo RT, Bozza FA et al. Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/cc chemokine ligand 2-deficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production. Shock 2006 26 : 457 63.
31. Murphey ED, Sherwood ER. Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression. Shock 2006 26 : 417 24.
32. Dinant S, Vetelainen RL, Florquin S, van Vliet AK, van Gulik TM. IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 2007 141 : 176 82.
33. John T, Muller RD, Oberholzer A et al. Interleukin-10 modulates pro-apoptotic effects of TNF-alpha in human articular chondrocytes in vitro. Cytokine 2007 40 : 226 34.
34. Werner T, Shkoda A, Haller D. Intestinal epithelial cell proteome in IL-10 deficient mice and IL-10 receptor reconstituted epithelial cells: impact on chronic inflammation. J Proteome Res 2007 6 : 3691 704.
35. Latifi SQ, O'Riordan MA, Levine AD. Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 2002 70 : 4441 6.
36. Marra LE, Zhang ZX, Joe B et al. IL-10 induces regulatory T cell apoptosis by up-regulation of the membrane form of TNF-alpha. J Immunol 2004 172 : 1028 35.
37. Roers A, Siewe L, Strittmatter E et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J Exp Med 2004 200 : 1289 97.
38. Oberholzer C, Tschoeke SK, Moldawer LL, Oberholzer A. Local thymic caspase-9 inhibition improves survival during polymicrobial sepsis in mice. J Mol Med 2006 84 : 389 95.
39. Oberholzer C, Tschoeke SK, Bahjat K et al. In vivo transduction of thymic dendritic cells with adenovirus and its potential use in acute inflammatory diseases. Scand J Immunol 2005 61 : 309 15.